ORKA-001 clinical trials

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

This study is testing a new medicine, ORKA-001, for people with moderate to severe plaque psoriasis. It aims to find the best dose and see how well it works and if it's safe compared to a dummy treatment.